目的:评价国产吉西他滨(泽菲)联合顺铂二线治疗晚期乳腺癌的疗效和不良反应。方法:34例晚期乳腺癌患者采用国产吉西他滨1000mg/m2,静脉滴注30min,第1、8天;顺铂25mg/m2,静脉滴注,第1～3天。21d为一个周期,至少完成两周期后评价疗效。结果:完全缓解2例(588%),部分缓解16例(4706%),总有效率为5294%。中位疾病进展时间为65月,中位生存期为114月;主要不良反应为骨髓抑制和胃肠道反应,所有不良反应在停药后或对症处理后均可恢复正常。结论:国产吉西他滨联合顺铂二线治疗晚期乳腺癌疗效较好,毒副反应可耐受,值得进一步研究。
Citation：
YAN Jun.. Observation of Domestic Gemcitabine Combined Cisplatin in the Second Line of Treatment of Patients with Metastatic Breast Cancer. West China Medical Journal, 2009, 24(5): 1178-1179. doi:
Copy
Copyright © the editorial department of West China Medical Journal of West China Medical Publisher. All rights reserved
| 1. |
SEIDMAN A D. Gemcitabine as singleagent therapy in the management of advanced breast cancer[J]. Oncology,2001,15(2):1114.
|
| 2. |
张志强,江泽飞,宋三泰.吉西他滨在乳腺癌化疗中的临床应用[J].国外医学肿瘤学分册,2003,30(2):132135.
|
| 3. |
RHA S Y, JEUNG H, KIM Y, et al. Efficacy of gemcitabine as a salvage treatment in breast cancer[C]. Proc ASCO,2002,21:A2038.
|
| 4. |
徐从高,张茂宏,杨兴季,等,译.癌—肿瘤学原理与实践[M].济南:山东科学技术出版社,2001:15891673.
|
| 5. |
HEINEMAN V. Gemcitabine plus cisplatin for the treatment of metastastic breast cancer[J]. Clin Breast Cancer,2002,3(suppl 1):2429.
|
- 1. SEIDMAN A D. Gemcitabine as singleagent therapy in the management of advanced breast cancer[J]. Oncology,2001,15(2):1114.
- 2. 张志强,江泽飞,宋三泰.吉西他滨在乳腺癌化疗中的临床应用[J].国外医学肿瘤学分册,2003,30(2):132135.
- 3. RHA S Y, JEUNG H, KIM Y, et al. Efficacy of gemcitabine as a salvage treatment in breast cancer[C]. Proc ASCO,2002,21:A2038.
- 4. 徐从高,张茂宏,杨兴季,等,译.癌—肿瘤学原理与实践[M].济南:山东科学技术出版社,2001:15891673.
- 5. HEINEMAN V. Gemcitabine plus cisplatin for the treatment of metastastic breast cancer[J]. Clin Breast Cancer,2002,3(suppl 1):2429.
